Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Julia M. Kempf"'
Autor:
Julia M. Kempf, Sabrina Weser, Michael D. Bartoschek, Klaus H. Metzeler, Binje Vick, Tobias Herold, Kerstin Völse, Raphael Mattes, Manuela Scholz, Lucas E. Wange, Moreno Festini, Enes Ugur, Maike Roas, Oliver Weigert, Sebastian Bultmann, Heinrich Leonhardt, Gunnar Schotta, Wolfgang Hiddemann, Irmela Jeremias, Karsten Spiekermann
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Chemotherapy resistance is the main impediment in the treatment of acute myeloid leukaemia (AML). Despite rapid advances, the various mechanisms inducing resistance development remain to be defined in detail. Here we report that loss-of-func
Externí odkaz:
https://doaj.org/article/0a2238e6e69947ba9113af2e76fa12bb
Autor:
Wen-Hsin Liu, Sophie M. Stief, Philipp A. Greif, Klaus H. Metzeler, Irmela Jeremias, Michael D. Bartoschek, Gunnar Schotta, Michela Carlet, Hilmar Quentmeier, Anna-Li Hanneforth, Heinrich Leonhardt, Maja Rothenberg-Thurley, Wolfgang Hiddemann, Sabrina Weser, Sebastian Vosberg, Karsten Spiekermann, Julia M. Kempf, Sebastian Bultmann, Helena Domínguez Moreno, Binje Vick, Raphael Mattes, Bianka Ksienzyk, Matthias Oettle, Belay Tizazu
Publikováno v:
Leukemia
Leukemia 34, 50-62 (2020)
Leukemia 34, 50-62 (2020)
Acute myeloid leukemia (AML) is an aggressive hematologic neoplasm resulting from the malignant transformation of myeloid progenitors. Despite intensive chemotherapy leading to initial treatment responses, relapse caused by intrinsic or acquired drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7af2bb72428e1b37d5f4bb399f480bb9
https://pubmed.ncbi.nlm.nih.gov/31201358
https://pubmed.ncbi.nlm.nih.gov/31201358